Initial inhaler choice in COPD: real-world evidence

In a real-world cohort (UK's CPRD), initiating inhaled treatment for COPD with ICS/LABA rather than LAMA improves exacerbation rate without significant increases in pneumonia rates in those with peripheral blood eosinophil counts >4% http://bit.ly/2OZpij5

Detalles Bibliográficos
Autor principal: Jones, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885333/
https://www.ncbi.nlm.nih.gov/pubmed/31803273
http://dx.doi.org/10.1183/20734735.0256-2019
_version_ 1783474721540538368
author Jones, Thomas
author_facet Jones, Thomas
author_sort Jones, Thomas
collection PubMed
description In a real-world cohort (UK's CPRD), initiating inhaled treatment for COPD with ICS/LABA rather than LAMA improves exacerbation rate without significant increases in pneumonia rates in those with peripheral blood eosinophil counts >4% http://bit.ly/2OZpij5
format Online
Article
Text
id pubmed-6885333
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-68853332019-12-04 Initial inhaler choice in COPD: real-world evidence Jones, Thomas Breathe (Sheff) Expert Opinion In a real-world cohort (UK's CPRD), initiating inhaled treatment for COPD with ICS/LABA rather than LAMA improves exacerbation rate without significant increases in pneumonia rates in those with peripheral blood eosinophil counts >4% http://bit.ly/2OZpij5 European Respiratory Society 2019-12 /pmc/articles/PMC6885333/ /pubmed/31803273 http://dx.doi.org/10.1183/20734735.0256-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Expert Opinion
Jones, Thomas
Initial inhaler choice in COPD: real-world evidence
title Initial inhaler choice in COPD: real-world evidence
title_full Initial inhaler choice in COPD: real-world evidence
title_fullStr Initial inhaler choice in COPD: real-world evidence
title_full_unstemmed Initial inhaler choice in COPD: real-world evidence
title_short Initial inhaler choice in COPD: real-world evidence
title_sort initial inhaler choice in copd: real-world evidence
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885333/
https://www.ncbi.nlm.nih.gov/pubmed/31803273
http://dx.doi.org/10.1183/20734735.0256-2019
work_keys_str_mv AT jonesthomas initialinhalerchoiceincopdrealworldevidence

Ejemplares similares